Woodline Partners’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.18M | Sell |
1,000,611
-686,929
| -41% | -$4.93M | 0.04% | 492 |
|
|
2025
Q1 | $10.1M | Buy |
1,687,540
+1,074,375
| +175% | +$6.44M | 0.07% | 360 |
|
|
2024
Q4 | $4.78M | Buy |
613,165
+12,589
| +2% | +$98.2K | 0.03% | 493 |
|
|
2024
Q3 | $6.49M | Buy |
600,576
+478
| +0.1% | +$5.16K | 0.05% | 356 |
|
|
2024
Q2 | $5.06M | Sell |
600,098
-98,280
| -14% | -$829K | 0.05% | 336 |
|
|
2024
Q1 | $4.69M | Sell |
698,378
-92,106
| -12% | -$619K | 0.04% | 366 |
|
|
2023
Q4 | $4.65M | Buy |
790,484
+670,484
| +559% | +$3.94M | 0.05% | 324 |
|
|
2023
Q3 | $1.17M | Buy |
+120,000
| New | +$1.17M | 0.01% | 433 |
|
|
2022
Q4 | – | Sell |
-69,871
| Closed | -$1.04M | – | 767 |
|
|
2022
Q3 | $1.04M | Buy |
+69,871
| New | +$1.04M | 0.01% | 528 |
|
|
2022
Q2 | – | Sell |
-36,783
| Closed | -$276K | – | 811 |
|
|
2022
Q1 | $276K | Buy |
+36,783
| New | +$276K | ﹤0.01% | 535 |
|